Published in Med Microbiol Immunol on January 01, 1984
A solid-phase radioimmunoassay for detection of IgM antibodies to hepatitis A virus. J Infect Dis (1979) 3.15
Palindrome resolution and recombination in the mammalian germ line. Mol Cell Biol (1997) 2.17
Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J Gen Virol (1980) 2.13
Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet (1991) 2.02
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol (1994) 1.80
Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood (1991) 1.74
Persistent infection of human fibroblasts by hepatitis A virus. J Gen Virol (1984) 1.72
Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J Infect Dis (1983) 1.56
Detection of hepatitis A virus in sewage sludge by antigen capture polymerase chain reaction. Appl Environ Microbiol (1993) 1.42
Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A. J Med Virol (1977) 1.39
Hepatitis A-virus in cell culture: I. propagation of different hepatitis A-virus isolates in a fetal rhesus monkey kidney cell line (Frhk-4). Med Microbiol Immunol (1980) 1.39
Liver-derived cytotoxic T cells in hepatitis A virus infection. J Infect Dis (1989) 1.29
Early diagnosis of herpes simplex encephalitis by MRI. Neurology (1987) 1.28
Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology (1987) 1.23
Hepatitis A virus in cell culture. II. Growth characteristics of hepatitis A virus in Frhk-4/R cells. Med Microbiol Immunol (1981) 1.21
Acid stability of hepatitis A virus. J Gen Virol (1989) 1.18
Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology (1990) 1.08
Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood (1993) 1.06
Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol (2000) 1.06
Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation. Virology (1994) 1.02
Antigenicity of hepatitis A virus after ultra-violet inactivation. Vaccine (1995) 1.02
Hepatitis A virus in cell culture. III. Propagation of hepatitis A virus in human embryo kidney cells and human embryo fibroblast strains. Med Microbiol Immunol (1981) 0.99
Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm(-3). Anesth Analg (1997) 0.99
Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection. J Virol (1988) 0.98
Treatment of incomplete analgesia after placement of an epidural catheter and administration of local anesthetic for women in labor. Anesthesiology (1998) 0.98
Comparison of ozone inactivation, in flowing water, of hepatitis A virus, poliovirus 1, and indicator organisms. Appl Environ Microbiol (1989) 0.95
A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J Virol (1998) 0.95
Application of a solid-phase radioimmunoassay and immune electron microscopy for hepatitis A in diagnosis and research. Med Microbiol Immunol (1978) 0.93
Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature (1981) 0.91
Recombination of influenza A strains with fowl plague virus can change pneumotropism for mice to a generalized infection with involvement of the central nervous system. Virology (1980) 0.91
Hepatitis A virus infection and the interferon system. J Infect Dis (1985) 0.91
High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Transplantation (1988) 0.90
Autoantibodies against human beta interferon following treatment with interferon. J Interferon Res (1982) 0.88
Properties of a hepatitis A virus candidate vaccine strain. J Gen Virol (1987) 0.88
Hepatitis A-virus particles in stools of patients from a natural hepatitis outbreak in Germany. Med Microbiol Immunol (1977) 0.88
Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction. Prenat Diagn (2014) 0.87
Levels of neutralizing and binding antibodies to hepatitis-A virus after onset of icterus: a comparison. J Infect Dis (1984) 0.87
Genetic relatedness of Cuban HAV wild-type isolates. J Med Virol (2001) 0.86
The proposed gene for VP1 of HAV encodes for a larger protein than that observed in HAV-infected cells and virions. Virology (1995) 0.85
Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients. J Med Virol (1996) 0.85
Epidural ropivacaine for the initiation of labor epidural analgesia: a dose finding study. Anesth Analg (1999) 0.85
Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection. J Med Virol (1986) 0.84
Transmission of hepatitis A virus infection despite vaccination. N Engl J Med (2000) 0.84
Detection of hepatitis A virus RNA in commercially available factor VIII preparation. Lancet (1992) 0.84
Immunogenicity of a hepatitis A virus vaccine. J Med Virol (1987) 0.84
Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update. Vox Sang (1994) 0.83
Isolated pericardial relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant (1989) 0.83
Significant reduction of cytomegalovirus (CMV) disease by prophylaxis with CMV hyperimmune globulin plus oral acyclovir. Bone Marrow Transplant (1988) 0.83
New epidemiological patterns of hepatitis A and B infections in Germany. Zentralbl Hyg Umweltmed (1995) 0.83
Influence of the 5' noncoding region of hepatitis A virus strain GBM on its growth in different cell lines. J Gen Virol (1997) 0.81
Influenza virus: association of mouse-lung virulence with plaque formation in mouse kidney cells. Intervirology (1976) 0.81
Specific detection of minus strand hepatitis A virus RNA by Tail-PCR following reverse transcription. Nucleic Acids Res (1994) 0.81
Subhypnotic doses of propofol do not relieve pruritus induced by intrathecal morphine after cesarean section. Anesth Analg (1998) 0.81
A double-blind comparison of nimesulide and mefenamic acid in the treatment of acute upper respiratory tract infections in children. Drugs (1993) 0.81
Inhibition of in vitro hematopoiesis by hepatitis A virus. Exp Hematol (1987) 0.81
Interferon-gamma secretion by in vivo activated cytotoxic T lymphocytes from the blood and cerebrospinal fluid during mumps meningitis. J Neuroimmunol (1991) 0.80
A comparison of enzyme-immunoassay and radioimmunoassay for detection of hepatitis A virus and antibodies against hepatitis A virus. J Biol Stand (1984) 0.80
Antitumor activity of the pineal gland: effect of unidentified substances versus the effect of melatonin. Oncology (1992) 0.80
Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients. Eur J Med Res (2011) 0.79
Myelopoiesis in vitro is suppressed by hepatitis A virus. Ann Hematol (1992) 0.79
Immunogenicity and efficacy of a killed hepatitis A vaccine in day care center children. J Med Virol (1996) 0.79
Characterization of cell mediated immune responses to the hepatitis B core protein in man. Clin Exp Immunol (1987) 0.79
Detection of hepatitis A virus in a factor VIII preparation by antigen capture/PCR. Vox Sang (1994) 0.78
Acute viral hepatitis, types A, B and non-A, non-B: a prospective study of the epidemiological, laboratory and prognostic aspects in 280 consecutive cases. Scand J Infect Dis (1981) 0.78
Immune response to hepatitis A virus capsid proteins after infection. J Clin Microbiol (1996) 0.78
Molecular epidemiology of an outbreak of hepatitis A in Italy. J Med Virol (1995) 0.77
Improvement of virus safety of a S/D-treated factor VIII concentrate by additional dry heat treatment at 100 degrees C. Biologicals (1996) 0.77
A severe human cowpox infection in south Germany. Pediatr Infect Dis J (1988) 0.76
Influenza virus: appearance of high mouse-neurovirulent recombinants. Intervirology (1979) 0.76
Functional significance of neuraminidase in the replication cycle of influenza viruses. Zentralbl Bakteriol Orig A (1975) 0.76
[Oral prophylaxis of herpes infections using acyclovir following bone marrow transplantation: a clinical and clinico-pharmacological study]. Klin Wochenschr (1986) 0.76
Hybridization techniques provide improved sensitivity for HCMV detection and allow quantitation of the virus in clinical samples. J Virol Methods (1989) 0.75
Hepatitis G virus infection. Lancet (1997) 0.75
Hepatitis C virus, rheumatoid factors, and disease progression. Lancet (1998) 0.75
Preliminary characterization of a fast-growing strain of human hepatitis A virus. Microbiologica (1986) 0.75
Transmission of hepatitis E virus by transfusion? Lancet (1993) 0.75
Quantitative determination of immune response against hepatitis A virus capsids after natural infection. Vaccine (1996) 0.75
Anti-hepatitis E virus markers in hemodialysis patients. Nephron (1996) 0.75
Hepatitis E virus in haemodialysis. Vox Sang (1997) 0.75
Hepatitis A virus and polymerase chain reaction amplification: methodology and results. Blood Coagul Fibrinolysis (1995) 0.75
Usher's syndrome. Ophthalmic Paediatr Genet (1990) 0.75
[A trial of a hepatitis A cultured inactivated vaccine on rhesus macaques]. Zh Mikrobiol Epidemiol Immunobiol (1995) 0.75